KEY METABOLITE KINETICS IN HUMAN SKELETAL-MUSCLE DURING ISCHEMIA AND REPERFUSION - MEASUREMENT BY MICRODIALYSIS

被引:60
作者
MULLER, M
SCHMID, R
NIESZPAURLOS, M
FASSOLT, A
LONNROTH, P
FASCHING, P
EICHLER, HG
机构
[1] UNIV VIENNA,DEPT CLIN PHARMACOL,A-1090 VIENNA,AUSTRIA
[2] UNIV VIENNA,DEPT MED & CHEM LAB DIAG,A-1090 VIENNA,AUSTRIA
[3] UNIV VIENNA,DEPT HEMATOL & HEMOSTASEOL,A-1090 VIENNA,AUSTRIA
[4] UNIV VIENNA,DEPT INTERNAL MED 3,DIV ENDOCRINOL & METAB,A-1090 VIENNA,AUSTRIA
[5] GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT MED,S-41124 GOTHENBURG,SWEDEN
关键词
D O I
10.1111/j.1365-2362.1995.tb01752.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The tissue kinetics of key metabolites of ischaemic and postischaemic tissue damage were studied in the intercellular space of human skeletal muscle by microdialysis. In vivo microdialysis calibration experiments (n=5) yielded the basal intercellular concentration of glucose in human skeletal muscle (3.6+/-0.6 mM; mean+/-SD). The corresponding mean plasma glucose concentration was 4.3+/-0.2 mM which was significantly higher. The time vs. concentration profiles of intercellular glucose (n=7), lactate (n=5), TxB(2) (n=6) and urea (n=8) were characterized during a 20 min period of leg constriction. TxB(2) increased exclusively during reperfusion in comparison to baseline (n=6). Administration of 500 mg acetylsalicylic acid, 5-10 min after onset of ischaemia blunted TxB(2)-response to reperfusion (n=4). It is concluded that intercellular muscle glucose concentration is less than that in plasma. Glucose uptake in skeletal muscle is rapid even under ischaemic conditions. Synthesis and release of TxB(2) is not evident during ischaemia. TxB(2) mediated reperfusion injury might be reduced by acetylsalicylic acid, even if administered after onset of ischaemia.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 40 条
  • [1] Dryski M., Swedenborg J., Acute ischemia of the extremities in a metropolitan area during one year, J Cardiovasc Surg, 25, pp. 518-522, (1994)
  • [2] Ljungman C., Adami HO, Bergqvist D., Berglund A., Persson I., Time trends in incidence rates of acute, non‐traumatic extremity ischemia: a population‐based study during a 19‐year period, Br J Surg, 78, 7, pp. 857-860, (1991)
  • [3] Ascer E., Mohan C., Gennaro M., Cupo S., Interleukin‐1 and thromboxane release after skeletal muscle ischemia and reperfusion, Ann Vasc Surg, 6, pp. 69-73, (1992)
  • [4] Grace PA., Ischemia‐reperfusion injury, Br J Surg, 81, pp. 637-647, (1994)
  • [5] Harris K., Walker PM, Mickle AG, Et al., Metabolic response of skeletal muscle to ischemia, Am J Physiol, 250, (1986)
  • [6] Larsson J., Hultman E., The effect of long‐term arterial occlusion on energy metabolism of the human quadriceps muscle, Scand J Clin Lab Invest, 39, pp. 257-264, (1979)
  • [7] Sundberg CJ, Kaijser L., Effects of graded restriction of perfusion on circulation and metabolism in the working leg
  • [8] quantification of a human ischaemia‐model, Acta Physiol Scand, 146, pp. 1-9, (1992)
  • [9] Welsh DG, Lindinger MI., Energy metabolism and adenine nucleotide degradation in twitch‐stimulated rat hindlimb during ischemia reperfusion, Am J Physiol, 64, (1993)
  • [10] Harris RC, Hultman E., Kaijser L., Nordesjo LO., The effect of circulatory occlusion on isometric exercise capacity and energy metabolism of the quadriceps muscle in man, Scand J Clin Lab Invest, 35, pp. 87-95, (1975)